Post-approval studies (Phase 4)UnknownNCT03887013
What this trial is testing
Cardiac Metabolic Modulator Treatment for Improvement of Diastolic Function in Patients With Coronary Heart Disease
Who this might be right for
Coronary Heart DiseaseDiastolic Dysfunction
China National Center for Cardiovascular Diseases 226